Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02973022 · ClinicalTrials.gov registry record
A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 66
- Enrollment target
NCT02973022: Completed study, sponsored by University of Wisconsin, Madison.
NCT02973022 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02973022 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the impact of participation in Cancer Clear and Simple (CC\&S) educational sessions on cancer prevention and screening. The researchers will recruit 60 community members: 30 will receive CC\&S training (intervention group) and 30 will not (control group). All 60 will be surveyed about their intent to change their behavior at the beginning of the study and their actual behavior changes and their screening behavior 6 months after enrollment in the study.
Primary Outcome
All 60 participants (30 intervention, 30 control group) will be surveyed about their intent to change their behavior at the beginning of the study and their actual behavior changes and their cancer screening behavior 6 months after enrollment in the study.
Interventions
- OTHER CC&S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-10-07 |
| Est. Completion | 2018-09-17 |
What the finished NCT02973022 record still lists
NCT02973022 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CC&S is the first listed.
NCT02973022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02973022 about?
NCT02973022 is a clinical study titled "A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2". The aim of this study is to evaluate the impact of participation in Cancer Clear and Simple (CC\&S) educational sessions on cancer prevention and screening. The researchers will recruit 60 community members: 30 will receive CC\&S training (intervention group) and 30 will not (control group). All 60 ...
What is the current status of trial NCT02973022?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2016-10-07. Estimated completion is 2018-09-17.
What interventions are being tested in trial NCT02973022?
The interventions under investigation include: CC&S (OTHER).
Who is sponsoring clinical trial NCT02973022?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI